As a tumor promotor, it induce HCC invasion and epithelial-to-mesenchymal transition (EMT) through active pro-EMT inducers, such as TWIST1, TCF3, E12, SNAI1, SLUG, ZEB1 [6–8]. The gene discussed is TWIST1; the disease is hepatocellular carcinoma.